Advanced searches left 3/3

Angina - ClinicalTrials.gov

Summarized by Plex Scholar
Last Updated: 10 September 2022

* If you want to update the article please login/register

REducing Microvascular Dysfunction in Patients With Angina, Ischaemia and unobstructED coronarY Arteries - a PILOT Study

Myocardial ischaemia is common in the midst of coronary microvascular abnormalities. The Coronary Sinus Reducer is a new drug for refractory angina, which causes a focal narrowing in the coronary sinus that increases back pressure and redistributes blood into ischaemic myocardium at the level of the microcirculation. REMEDY-PILOT's mechanistic subset will investigate the possibility that CS Reducer implantation alters measures of invasive coronary microcirculatory physiology as the mechanistic explanation for observed changes in quantitative CMR stress perfusion, symptoms, and quality of life.

Source link: https://clinicaltrials.gov/ct2/show/NCT05492110

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions